$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 ... 15 16 17 18 19 20 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 31 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 4,000 | 44,874 | 4,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 355,000 | 3,982,568 | 375,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 17,000 | 190,715 | 20,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 3,000 | 33,656 | 3,000 | |
Jan 24 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.62 | 7 | 74 | 131,533 | 131.5 K to 131.5 K (+0.01 %) |
Jan 31 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 17,781,000 | 199,476,149 | 29,593,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 831,000 | 9,322,574 | 11,812,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 117,000 | 1,312,565 | 10,981,000 | |
Jan 24 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.62 | 223 | 2,368 | 5,427,876 | 5.4 M to 5.4 M (0.00 %) |
Jan 24 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.62 | 65 | 690 | 3,046,922 | 3 M to 3 M (0.00 %) |
Jan 24 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.62 | 4 | 42 | 129,057 | 129.1 K to 129.1 K (0.00 %) |
Jan 24 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.62 | 1 | 11 | 282,044 | 282 K to 282 K (0.00 %) |
Jan 16 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.99 | 94 | 1,033 | 282,043 | 281.9 K to 282 K (+0.03 %) |
Jan 16 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.99 | 34,621 | 380,398 | 5,427,653 | 5.4 M to 5.4 M (+0.64 %) |
Jan 16 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.99 | 723 | 7,944 | 129,053 | 128.3 K to 129.1 K (+0.56 %) |
Jan 16 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.99 | 1,101 | 12,097 | 131,526 | 130.4 K to 131.5 K (+0.84 %) |
Jan 16 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.99 | 13,675 | 150,254 | 3,046,857 | 3 M to 3 M (+0.45 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.94 | 84 | 919 | 281,949 | 281.9 K to 281.9 K (+0.03 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 11.01 | 3 | 33 | 281,865 | 281.9 K to 281.9 K (0.00 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.94 | 247 | 2,703 | 281,862 | 281.6 K to 281.9 K (+0.09 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.94 | 12,120 | 132,548 | 3,033,182 | 3 M to 3 M (+0.40 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 11.01 | 490 | 5,392 | 3,021,062 | 3 M to 3 M (+0.02 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.94 | 35,783 | 391,566 | 3,020,572 | 3 M to 3 M (+1.20 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.94 | 30,682 | 335,548 | 5,393,032 | 5.4 M to 5.4 M (+0.57 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 11.01 | 1,241 | 13,657 | 5,362,350 | 5.4 M to 5.4 M (+0.02 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.94 | 90,591 | 991,319 | 5,361,109 | 5.3 M to 5.4 M (+1.72 %) |
Jan 11 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.94 | 973 | 10,641 | 130,425 | 129.5 K to 130.4 K (+0.75 %) |
Jan 11 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 11.01 | 40 | 440 | 129,452 | 129.4 K to 129.5 K (+0.03 %) |
Jan 11 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.94 | 2,878 | 31,493 | 129,412 | 126.5 K to 129.4 K (+2.27 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.94 | 641 | 7,010 | 128,330 | 127.7 K to 128.3 K (+0.50 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 11.01 | 26 | 286 | 127,689 | 127.7 K to 127.7 K (+0.02 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.94 | 1,892 | 20,704 | 127,663 | 125.8 K to 127.7 K (+1.50 %) |
Jan 08 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.00 | 768 | 7,677 | 126,534 | 125.8 K to 126.5 K (+0.61 %) |
Jan 08 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.89 | 14,569 | 158,715 | 125,766 | 111.2 K to 125.8 K (+13.10 %) |
Jan 08 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 9.48 | 6,744 | 63,941 | 111,197 | 104.5 K to 111.2 K (+6.46 %) |
Jan 08 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 9.47 | 9,492 | 89,857 | 104,453 | 95 K to 104.5 K (+10.00 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.00 | 24,154 | 241,434 | 5,270,518 | 5.2 M to 5.3 M (+0.46 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.89 | 458,644 | 4,996,468 | 5,246,364 | 4.8 M to 5.2 M (+9.58 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.48 | 212,282 | 2,012,667 | 4,787,720 | 4.6 M to 4.8 M (+4.64 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.47 | 298,752 | 2,828,166 | 4,575,438 | 4.3 M to 4.6 M (+6.99 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.00 | 9,541 | 95,368 | 2,984,789 | 3 M to 3 M (+0.32 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.89 | 181,168 | 1,973,644 | 2,975,248 | 2.8 M to 3 M (+6.48 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.48 | 83,853 | 795,019 | 2,794,080 | 2.7 M to 2.8 M (+3.09 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.47 | 118,009 | 1,117,144 | 2,710,227 | 2.6 M to 2.7 M (+4.55 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.00 | 66 | 660 | 281,615 | 281.5 K to 281.6 K (+0.02 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.89 | 1,252 | 13,639 | 281,549 | 280.3 K to 281.5 K (+0.45 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.48 | 579 | 5,490 | 280,297 | 279.7 K to 280.3 K (+0.21 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.47 | 815 | 7,715 | 279,718 | 278.9 K to 279.7 K (+0.29 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.00 | 504 | 5,038 | 125,771 | 125.3 K to 125.8 K (+0.40 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.89 | 9,576 | 104,321 | 125,267 | 115.7 K to 125.3 K (+8.28 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.48 | 4,432 | 42,020 | 115,691 | 111.3 K to 115.7 K (+3.98 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.47 | 6,237 | 59,043 | 111,259 | 105 K to 111.3 K (+5.94 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.61 | 1,862 | 19,752 | 105,022 | 103.2 K to 105 K (+1.80 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.58 | 1,124 | 11,896 | 103,160 | 102 K to 103.2 K (+1.10 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.60 | 1,974 | 20,915 | 102,036 | 100.1 K to 102 K (+1.97 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.61 | 243 | 2,578 | 278,903 | 278.7 K to 278.9 K (+0.09 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.58 | 147 | 1,556 | 278,660 | 278.5 K to 278.7 K (+0.05 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.60 | 258 | 2,734 | 278,513 | 278.3 K to 278.5 K (+0.09 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.61 | 35,234 | 373,755 | 2,592,218 | 2.6 M to 2.6 M (+1.38 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.58 | 21,261 | 225,020 | 2,556,984 | 2.5 M to 2.6 M (+0.84 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.60 | 37,354 | 395,777 | 2,535,723 | 2.5 M to 2.5 M (+1.50 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.61 | 89,198 | 946,195 | 4,276,686 | 4.2 M to 4.3 M (+2.13 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.58 | 53,824 | 569,657 | 4,187,488 | 4.1 M to 4.2 M (+1.30 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.60 | 94,565 | 1,001,945 | 4,133,664 | 4 M to 4.1 M (+2.34 %) |
Dec 19 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.61 | 2,834 | 30,063 | 94,961 | 92.1 K to 95 K (+3.08 %) |
Dec 19 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.58 | 1,710 | 18,098 | 92,127 | 90.4 K to 92.1 K (+1.89 %) |
Dec 19 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.60 | 3,005 | 31,839 | 90,417 | 87.4 K to 90.4 K (+3.44 %) |
Dec 13 2007 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Gift | G | 0.00 | 3,654 | 0 | 971,335 | 975 K to 971.3 K (-0.37 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.38 | 170,512 | 1,770,750 | 4,039,099 | 3.9 M to 4 M (+4.41 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.85 | 66,672 | 656,779 | 3,868,587 | 3.8 M to 3.9 M (+1.75 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.87 | 87,770 | 866,465 | 3,801,915 | 3.7 M to 3.8 M (+2.36 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.54 | 108,461 | 1,035,184 | 3,714,145 | 3.6 M to 3.7 M (+3.01 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.38 | 67,353 | 699,454 | 2,498,369 | 2.4 M to 2.5 M (+2.77 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.85 | 26,336 | 259,433 | 2,431,016 | 2.4 M to 2.4 M (+1.10 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.87 | 34,670 | 342,262 | 2,404,680 | 2.4 M to 2.4 M (+1.46 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.54 | 42,843 | 408,906 | 2,370,010 | 2.3 M to 2.4 M (+1.84 %) |
Dec 12 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 10.38 | 5,418 | 56,265 | 87,412 | 82 K to 87.4 K (+6.61 %) |
Dec 12 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 9.85 | 2,118 | 20,864 | 81,994 | 79.9 K to 82 K (+2.65 %) |
Dec 12 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 9.87 | 2,788 | 27,523 | 79,876 | 77.1 K to 79.9 K (+3.62 %) |
Dec 12 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 9.54 | 3,445 | 32,880 | 77,088 | 73.6 K to 77.1 K (+4.68 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.38 | 465 | 4,829 | 278,255 | 277.8 K to 278.3 K (+0.17 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.85 | 182 | 1,793 | 277,790 | 277.6 K to 277.8 K (+0.07 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.87 | 240 | 2,369 | 277,608 | 277.4 K to 277.6 K (+0.09 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.54 | 296 | 2,825 | 277,368 | 277.1 K to 277.4 K (+0.11 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.38 | 3,560 | 36,970 | 100,062 | 96.5 K to 100.1 K (+3.69 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.85 | 1,392 | 13,712 | 96,502 | 95.1 K to 96.5 K (+1.46 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.87 | 1,832 | 18,086 | 95,110 | 93.3 K to 95.1 K (+1.96 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.54 | 2,265 | 21,618 | 93,278 | 91 K to 93.3 K (+2.49 %) |
Dec 06 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.98 | 19,593 | 175,980 | 2,327,167 | 2.3 M to 2.3 M (+0.85 %) |
Dec 06 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.98 | 1,139 | 10,230 | 91,013 | 89.9 K to 91 K (+1.27 %) |
Dec 06 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.98 | 1,812 | 16,275 | 73,643 | 71.8 K to 73.6 K (+2.52 %) |
Dec 06 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.98 | 57,303 | 514,684 | 3,605,684 | 3.5 M to 3.6 M (+1.61 %) |
Dec 06 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.98 | 153 | 1,374 | 277,072 | 276.9 K to 277.1 K (+0.06 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.96 | 4,241 | 38,007 | 2,307,574 | 2.3 M to 2.3 M (+0.18 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.59 | 9,764 | 83,882 | 2,303,333 | 2.3 M to 2.3 M (+0.43 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.58 | 3,125 | 26,809 | 2,293,569 | 2.3 M to 2.3 M (+0.14 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.96 | 23,842 | 213,665 | 3,548,381 | 3.5 M to 3.5 M (+0.68 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.59 | 54,899 | 471,632 | 3,524,539 | 3.5 M to 3.5 M (+1.58 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.58 | 17,572 | 150,747 | 3,469,640 | 3.5 M to 3.5 M (+0.51 %) |
Dec 03 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.96 | 753 | 6,748 | 71,831 | 71.1 K to 71.8 K (+1.06 %) |
Dec 03 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.59 | 1,734 | 14,897 | 71,078 | 69.3 K to 71.1 K (+2.50 %) |
Dec 03 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.58 | 556 | 4,770 | 69,344 | 68.8 K to 69.3 K (+0.81 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.40 | 22,741 | 190,940 | 2,290,444 | 2.3 M to 2.3 M (+1.00 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.00 | 35,237 | 281,797 | 2,267,703 | 2.2 M to 2.3 M (+1.58 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 7.94 | 15,282 | 121,322 | 2,232,466 | 2.2 M to 2.2 M (+0.69 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.40 | 342 | 2,872 | 276,661 | 276.3 K to 276.7 K (+0.12 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.00 | 530 | 4,239 | 276,319 | 275.8 K to 276.3 K (+0.19 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.94 | 230 | 1,826 | 275,789 | 275.6 K to 275.8 K (+0.08 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.96 | 64 | 574 | 276,919 | 276.9 K to 276.9 K (+0.02 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.59 | 147 | 1,263 | 276,855 | 276.7 K to 276.9 K (+0.05 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.58 | 47 | 403 | 276,708 | 276.7 K to 276.7 K (+0.02 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.40 | 127,875 | 1,073,677 | 3,452,068 | 3.3 M to 3.5 M (+3.85 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.00 | 198,138 | 1,584,549 | 3,324,193 | 3.1 M to 3.3 M (+6.34 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 7.94 | 85,927 | 682,166 | 3,126,055 | 3 M to 3.1 M (+2.83 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.12 | 9,961 | 80,883 | 2,217,184 | 2.2 M to 2.2 M (+0.45 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.10 | 13,945 | 112,974 | 2,207,223 | 2.2 M to 2.2 M (+0.64 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.22 | 46,836 | 385,151 | 2,193,278 | 2.1 M to 2.2 M (+2.18 %) |
Nov 28 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.40 | 4,042 | 33,938 | 68,788 | 64.7 K to 68.8 K (+6.24 %) |
Nov 28 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.00 | 6,262 | 50,078 | 64,746 | 58.5 K to 64.7 K (+10.71 %) |
Nov 28 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 7.94 | 2,715 | 21,554 | 58,484 | 55.8 K to 58.5 K (+4.87 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.12 | 56,010 | 454,801 | 3,040,128 | 3 M to 3 M (+1.88 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.10 | 78,415 | 635,271 | 2,984,118 | 2.9 M to 3 M (+2.70 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.22 | 144,486 | 1,188,166 | 2,905,703 | 2.8 M to 2.9 M (+5.23 %) |
Nov 21 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.12 | 1,770 | 14,372 | 55,769 | 54 K to 55.8 K (+3.28 %) |
Nov 21 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.10 | 2,478 | 20,075 | 53,999 | 51.5 K to 54 K (+4.81 %) |
Nov 21 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.22 | 4,566 | 37,548 | 51,521 | 47 K to 51.5 K (+9.72 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.12 | 150 | 1,218 | 275,559 | 275.4 K to 275.6 K (+0.05 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.10 | 210 | 1,701 | 275,409 | 275.2 K to 275.4 K (+0.08 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.22 | 387 | 3,182 | 275,199 | 274.8 K to 275.2 K (+0.14 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.22 | 318 | 2,615 | 89,874 | 89.6 K to 89.9 K (+0.36 %) |
Nov 16 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.30 | 3,232 | 26,834 | 46,955 | 43.7 K to 47 K (+7.39 %) |
Nov 16 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.63 | 5 | 43 | 43,723 | 43.7 K to 43.7 K (+0.01 %) |
Nov 16 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.62 | 3,421 | 29,499 | 43,718 | 40.3 K to 43.7 K (+8.49 %) |
Nov 16 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.53 | 3,949 | 33,676 | 40,297 | 36.3 K to 40.3 K (+10.86 %) |
Nov 16 2007 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 8.54 | 57 | 487 | 36,348 | 36.3 K to 36.3 K (+0.16 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.30 | 102,285 | 849,221 | 2,761,217 | 2.7 M to 2.8 M (+3.85 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.63 | 151 | 1,303 | 2,658,932 | 2.7 M to 2.7 M (+0.01 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.62 | 108,254 | 933,463 | 2,658,781 | 2.6 M to 2.7 M (+4.24 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.53 | 124,973 | 1,065,732 | 2,550,527 | 2.4 M to 2.6 M (+5.15 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.54 | 1,793 | 15,312 | 2,425,554 | 2.4 M to 2.4 M (+0.07 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.30 | 33,157 | 275,286 | 2,146,442 | 2.1 M to 2.1 M (+1.57 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.63 | 60 | 518 | 2,113,285 | 2.1 M to 2.1 M (0.00 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.62 | 42,783 | 368,914 | 2,113,225 | 2.1 M to 2.1 M (+2.07 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.53 | 49,390 | 421,183 | 2,070,442 | 2 M to 2.1 M (+2.44 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.54 | 709 | 6,055 | 2,021,052 | 2 M to 2 M (+0.04 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.30 | 274 | 2,275 | 274,812 | 274.5 K to 274.8 K (+0.10 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.62 | 290 | 2,501 | 274,538 | 274.2 K to 274.5 K (+0.11 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.53 | 335 | 2,857 | 274,248 | 273.9 K to 274.2 K (+0.12 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.54 | 5 | 43 | 273,913 | 273.9 K to 273.9 K (0.00 %) |
Nov 15 2007 | INCY | INCYTE CORP | DE SCHUTTER RICHARD U | Director | Option Exercise | M | 3.86 | 20,000 | 77,200 | 0 |